Objective To evaluate the safety and efficacy of dose-reduced transarterial chemoembolization(TACE)for primary liver cancer patients with obstructive jaundice.Methods Twenty-four primary liver cancer patients with single tumor and obstructive jaundice undergoing dose-reduced TACE were retrospectively analyzed.Results The overall median survival time of 24 patients was 9.0 months.The 1-,2-and 3-year cumulative survival rates were 33.3%,22.2% and16.6%.Tumor size and AFP level were significant predicting facto...